NCT00004940View on ClinicalTrials.gov

Phase III Study of L-Cysteine in Patients With Erythropoietic Protoporphyria

PHASE3CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

May 31, 1996

Study Completion Date

September 30, 2001

Conditions

Erythropoietic Protoporphyria

Interventions

DRUG

cysteine hydrochloride

All Listed Sponsors

lead

Brigham and Women's Hospital

OTHER